Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus Infection.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 07 03 2024
accepted: 07 09 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 30 9 2024
Statut: aheadofprint

Résumé

Expression of T cell Ig and mucin domain-containing protein 3 (Tim-3) is upregulated on regulatory T cells (Tregs) during chronic viral infections. In several murine and human chronic infections, the expression of Tim-3 is associated with poor control of viral burden and impaired antiviral immune responses. However, the role of Tim-3+ Tregs during persistent viral infections has not been fully defined. We employed an inducible Treg-specific Tim-3 loss-of-function (Tim-3 Treg knockout) murine model to dissect the role of Tim-3 on Tregs during chronic lymphocytic choriomeningitis virus infection. Tim-3 Treg knockout mice exhibited a decrease in morbidity, a more potent virus-specific T cell response, and a significant decrease in viral burden. These mice also had a reduction in the frequency of PD-1+Tim-3+ and PD-1+Tox+ gp33-specific exhausted CD8+ T cells. Our findings demonstrate that modulation of a single surface protein on Tregs can lead to a reduction in viral burden, limit T cell exhaustion, and enhance gp33-specific T cell response. These studies may help to identify Tim-3-directed therapies for the management of persistent infections and cancer.

Identifiants

pubmed: 39345172
pii: 267175
doi: 10.4049/jimmunol.2400119
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : HHS | NIH | NCI | Center for Cancer Research (CCR)
ID : R01CA206517
Organisme : HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID)
ID : R01AI138504
Organisme : HHS | NIH | NCI | Center for Cancer Research (CCR)
ID : T32CA082084
Organisme : HHS | NIH | NCI | Center for Cancer Research (CCR)
ID : F31CA261039
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : T32GM008208
Organisme : HHS | NIH | NIH Office of the Director (OD)
ID : S10OD032265

Informations de copyright

Copyright © 2024 by The American Association of Immunologists, Inc.

Auteurs

Hector M Nieves-Rosado (HM)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Medical Scientist Training Program, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, PA.
Graduate Program in Microbiology and Immunology, University of Pittsburgh, Pittsburgh, PA.

Hridesh Banerjee (H)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.

Angela Gocher-Demske (A)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.

Priyanka Manandhar (P)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Graduate Program in Microbiology and Immunology, University of Pittsburgh, Pittsburgh, PA.

Isha Mehta (I)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Center for Systems Immunology, University of Pittsburgh, Pittsburgh, PA.

Ogechukwu Ezenwa (O)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Center for Systems Immunology, University of Pittsburgh, Pittsburgh, PA.

Bingxian Xie (B)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA.

Ben Murter (B)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Graduate Program in Microbiology and Immunology, University of Pittsburgh, Pittsburgh, PA.

Jishnu Das (J)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Center for Systems Immunology, University of Pittsburgh, Pittsburgh, PA.

Dario A A Vignali (DAA)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.

Greg M Delgoffe (GM)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA.

Lawrence P Kane (LP)

Department of Immunology, University of Pittsburgh, Pittsburgh, PA.

Classifications MeSH